Condition: Non-cystic Fibrosis Bronchiectasis · Chronic Obstructive Pulmonary Disease · Sponsor: Genentech, Inc.
This study evaluates the safety, tolerability, and activity of inhaled GDC-6988 in participants with muco-obstructive disease.
This description comes directly from the study's public registry record.
Reference Study ID Number: GB45429 https://forpatients.roche.com/ · 888-662-6728 (U.S. Only) · global-roche-genentech-trials@gene.com
Fastest response: use the inquiry form. No email attachments. https://www.gene.com/contact-us/submit-medical-inquiry
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham | Birmingham, Alabama, United States | Recruiting |
| Accel Research Site - Achieve - Birmingham - ERN - PPDS | Vestavia Hills, Alabama, United States | Withdrawn |
| Stanford Center for Excellence in Pulmonary Biology | Palo Alto, California, United States | Recruiting |
| University of Kansas Medical Center-Kansas City-3901 Rainbow Blvd | Kansas City, Kansas, United States | Recruiting |
| University of North Carolina Clinical Research Center | Chapel Hill, North Carolina, United States | Recruiting |
| UPMC Montefiore Hospital | Pittsburgh, Pennsylvania, United States | Recruiting |
| TTS Research | Boerne, Texas, United States | Completed |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06603246